|
|
||||||||
J Thorac Cardiovasc Surg 2008;136:1207-1214
© 2008 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
The Heart Center, Hospital for Sick Children, Toronto, Ontario, Canada
Received for publication August 24, 2007; revisions received October 17, 2007; accepted for publication February 25, 2008. * Reprint requests: Jia Li, MD, PhD, Division of Cardiology, The Heart Center, Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8. (Email: jia.li{at}yahoo.com).
| Abstract |
|---|
|
|
|---|
Methods: Seven sedated, paralyzed, and mechanically ventilated neonates were studied after the Norwood procedure. Arterial carbon dioxide tension increased from 40-50-60 mm Hg using inspired carbon dioxide. Each step was 30 minutes. Pulmonary and systemic blood flow, vascular resistance, and oxygen delivery were calculated with the measurement of oxygen consumption and blood gases and pressures from the aorta, superior vena cava, and pulmonary vein. Plasma epinephrine and norepinephrine were measured. Cerebral and splanchnic oxygen saturations were measured by near-infrared spectroscopy, and cerebral blood flow velocity was measured by transcranial Doppler.
Results: Stepwise increase in arterial carbon dioxide tension was associated with a decrease in systemic vascular resistance (P < .001) and an increase in systemic blood flow (P < .01) and oxygen delivery (P < .0001), but not with significant changes in total pulmonary vascular resistance and pulmonary blood flow. Cerebral oxygen saturation increased (P < .0001), and splanchnic oxygen saturation decreased (P < .01). Oxygen consumption decreased (P < .01), and epinephrine and norepinephrine increased (P < .01 and .05).
Conclusion: Moderate hypercapnia increases systemic blood flow because of its effect on systemic vascular resistance after the Norwood procedure. The increase in systemic blood flow is primarily a consequence of increased cerebral blood flow that compromises splanchnic circulation. The decrease in oxygen consumption improves oxygen transport, but the increase in catecholamines may be undesirable. Clinical use of carbon dioxide aiming to improve oxygen delivery should be with caution.
| Introduction |
|---|
|
|
|---|
Carbon dioxide (CO2) has been suggested to increase DO2 in neonates both before and after the Norwood procedure.2-6
Consequently, it is a common practice to maintain a relatively high arterial CO2 tension (PaCO
2) mostly by hypoventilation. It is believed that the potent pulmonary vasoconstrictive effect of CO2 decreases pulmonary blood flow (Qp), and Qp:Qs thereby increases Qs. This may be incorrect. As we have recently reported, using directly measured systemic hemodynamics and oxygen transport, Qp has little impact on DO2 in the presence of mechanical limitation by the Blalock-Taussig shunt and relative fixed total pulmonary vascular resistance (tPVR) (inclusive of the resistance of the Blalock-Taussig shunt and pulmonary vascular bed), and DO2 is mostly determined by SVR.1
Given the potent vasodilating effect of CO2 on systemic circulation,7
particularly the cerebral vascular bed,8,9
it was hypothesized that the increase in Qs and DO2 by CO2 may be the result of its effect on systemic circulation rather than the pulmonary vasculature, and that the increase in Qs may be the result of an increase in cerebral blood flow instead of splanchnic perfusion.
Near-infrared spectroscopy (NIRS) measures the equilibrium of oxyhemoglobin and deoxyhemoglobin in a mixture of veins, arteries, and capillaries in the underlying tissue and provides a noninvasive, continuous method to monitor regional tissue oxygenation.10
NIRS has been extensively evaluated in the cerebral10
and splanchnic11
circulations of newborn infants and was adapted to continuously monitor cerebral oxygen saturation (ScO2) and splanchnic oxygen saturation (SsO2) in the present study.
This study aimed to quantitatively define the effects of a stepwise increase in PaCO 2 on the systemic hemodynamics, oxygen transport, and redistribution of systemic DO2 between cerebral and splanchnic circulations in neonates during the early postoperative period after the Norwood procedure.
| Materials and Methods |
|---|
|
|
|---|
|
Postoperative Management
The central temperature (esophageal) was maintained between 36°C and 37°C. Postoperative monitoring included arterial, superior vena caval, and pulmonary venous pressures, and heart rate. Sedation consisted of continuous intravenous infusion of morphine and intermittent injections of a muscle relaxant (pancuronium). Patients received time-cycled pressure control/pressure support ventilation. Hemoglobin was maintained between 14 and 16 mg/dL. Inotropic and vasoactive agents (dopamine, milrinone, and phenoxybenzamine) and volume infusions (5% albumin or blood) were administered according to our standard protocol.13
Methods of Measurements
Systemic oxygen consumption
VO2 was measured continuously using an AMIS2000 respiratory mass spectrometer (Innovision A/S, Odense, Denmark). This is a sensitive and accurate method for continuous gas analysis that allows simultaneous measurements of multiple gas fractions.1
Inspired and end-tidal partial pressures of CO2 were continuously monitored using inlet sampling from the connection of the ventilator circuit to the endotracheal tube. This was used to estimate the rate of CO2 delivery into the inspired gas mixture.14
The setup of the CO2 delivery and respiratory mass spectrometer with the ventilator circuit is described elsewhere.15
Calculations of hemodynamics and oxygen transport
Blood samples were taken from the arterial, superior vena caval, and pulmonary venous lines for the measurements of blood gases. Qp, Qs, SVR, tPVR, DO2, and oxygen extraction ratio (ERO2) were calculated using standard equations (Table 2
).
|
Cerebral blood flow velocity
The flow velocity was measured with transcranial Doppler with a 2 MHz pulse-wave ultrasound transducer, which was fixed above the zygomatic arch (Medasonics Inc, Fremont, Calif) and interrogated the portion of middle cerebral artery near its junction with the anterior cerebral artery.9
Plasma norepinephrine and epinephrine
An arterial blood sample of 2 mL was withdrawn into an EDTA tube. The simultaneous determination of plasma norepinephrine and epinephrine was measured by high-performance liquid chromatography coupled with electrochemical detection.17
Study Protocol
The study protocol was instituted during the period of 48 to 72 hours after the Norwood procedure when a relatively cardiorespiratory steady state was achieved. Inspiratory O2 fraction was 0.21 to 0.25. The protocol consisted of 4 stages. At baseline, PaCO
2 was adjusted to 40 mm Hg by modifying minute ventilation. Subsequently, CO2 was delivered to the inspired gas mixture to reach PaCO
2 tensions of 50 and 60 mm Hg sequentially. Finally, additional CO2 was withdrawn and the measurements were repeated at a PaCO
2 of approximately 40 mm Hg. Each stage was for 30 minutes. At the end of each stage, blood gases (including arterial lactate), systemic hemodynamics and oxygen transport, ScO2 and SsO2, and cerebral arterial blood flow velocity were recorded, and arterial blood samples were taken for the measurements of plasma epinephrine and norepinephrine. Before the study, echocardiography was performed to ensure that the aortic arch and Blalock-Taussig shunt were unobstructed.
Statistics
The results are given as mean ± standard deviation. The data, collected at 4 levels of PaCO
2 (40, 50, and 60 mm Hg, and then 40 mm Hg), were analyzed by repeated-measures analysis of variance for quadratic effect. A quadratic effect was indicated by a statistically significant parameter estimate for the time sequence effect. The actual estimate for the inverted parabolas was negative, indicating a return toward baseline for the outcome. Pairwise comparison was performed between the data at different levels of CO2. The overall P value and adjusted P value for multiple comparisons were calculated using the Tukey-Kramer adjustment. We used the statistical software SAS version 8.2 (Cary, NC).
| Results |
|---|
|
|
|---|
Changes During the Study Protocol
The stepwise increase in PaCO
2 from 40 ± 4 to 53 ± 5 to 61 ± 6 mm Hg led to a decrease in arterial pH from 7.39 ± 0.05 to 7.28 ± 0.07 to 7.23 ± 0.08 (P < .0001) (Table 3
; Figure 1
). This was not associated with any significant change in tPVR, Qp, SaO2, or pulmonary venous O2 saturation. The stepwise increase in PaCO
2 was associated with a significant decrease in SVR (P < .001) and Qp:Qs (P < .05), and a significant increase in arterial oxygen tension (PaO
2) (P < .0001), Qs (P < .01), and DO2 (P < .0001). A significant decrease in central body temperature (P < .05), VO2 (P < .01), ERO2 (P < .01), and lactate (P < .001) were observed. Norepinephrine (P < .05) and epinephrine (P < .01) significantly increased. Cerebral arterial blood flow peak velocity and ScO2, as well as superior vena caval O2 saturation, significantly increased (P < .0001 for all), whereas SsO2 significantly decreased (P < .01). These changes were significantly greater when PaCO
2 increased from 40 to 50 mm Hg compared with PaCO
2 from 50 to 60 mm Hg, including PaO
2 (P < .0001), VO2 (P < .05), lactate (P < .05), cerebral arterial blood flow peak velocity (P < .01), ScO2 (P < .0001), superior venous O2 saturation (P < .0001), and norepinephrine (P < .05). DO2 increased significantly at both stages of PaCO
2 (P < .05). The changes in the remaining variables (temperature, SVR, Qs, Qp:Qs, CO, ERO2) did not achieve statistical significance between either of the 2 sequential stages, despite the significant changes over the 3 levels of PaCO
2. There was a small although insignificant increase in heart rate and arterial blood pressure over the stepwise increase in PaCO
2. As PaCO
2 decreased from 60 ± 6 mm Hg to 44 ± 5 mm Hg with discontinuation of added CO2, these variables returned toward baseline.
|
|
| Discussion |
|---|
|
|
|---|
Carbon Dioxide Effects: Pulmonary Versus Systemic Circulation
CO2 increases pulmonary vascular resistance (PVR) in biventricular circulation, and this has been generally used to explain the mechanisms for the increase in Qs and DO2 in the univentricular and parallel circulation as by decreasing Qp and Qp:Qs.2-5
On the basis of this speculation, hypoxia and hypercapnia as potent pulmonary vasoconstrictors were advocated. Although hypoxia fails to improve DO2 and may even be deleterious,3,5
induced hypercapnia mostly by hypoventilation remains a common practice aiming to improve DO2.5,6
Although the present data support previous findings, they reveal that the increase in Qs and DO2 during hypercapnia is due to the direct effect on the systemic circulation rather than the pulmonary circulation. This is supported by little changes in tPVR and Qp. In other words, in the presence of mechanical limitation by the Blalock-Taussig shunt, the change in PVR per se plays a limited role to determine tPVR and Qp. We have recently demonstrated that tPVR has little impact on DO2, and that SVR is the most important determinant of Qs and DO2 in neonates after the Norwood procedure.1
It should be remembered that CO2 is also a potent systemic vasodilator via its action on smooth muscle cells and endothelium of peripheral and cerebral arteries.7,8
The decrease in SVR and the consequent increase in Qs and DO2 during hypercapnia are clearly demonstrated in the present data. Systemic afterload reduction with agents such as alpha-blockade phenoxybenzamine nitric oxide donor sodium nitroprusside or a phosphodiesterase III inhibitor milrinone has been increasingly used as a primary management strategy in these patients both before and after the Norwood procedure, with improved postoperative outcomes.13,18-20
Therefore, in the concept of optimization of DO2 in the Norwood or single-ventricle physiology, emphasis should shift from PVR and Qp, even beyond Qp:Qs, directly to SVR and Qs.
In addition, hypercapnia produced a significant increase in PaO
2, with no significant change in SaO2 in the present study. This apparent contradiction is likely explained by the fact that increased PaCO
2 and acidosis cause a rightward shift in the oxyhemoglobin dissociation curve (Bohr effect), and for any given systemic saturation, PaO
2 is higher. The increase in PaO
2 may also contribute, to some extent, to the increase in DO2. Indeed, judicious use of higher inspired oxygen fraction has been suggested to improve DO2 in patients undergoing the Norwood procedure.21,22
Bradley and colleagues21
recently showed an improved DO2 (using indirect indicator of oxygen excess factor) by high inspired oxygen fraction, even with its potent pulmonary vasodilating effect. This further emphasizes the limited contribution of PVR to DO2 in the Norwood circulation.
Carbon Dioxide Effects: Upper Body Versus Lower Body Blood Flow
All the previous clinical studies have used superior vena caval oxygen saturation as a surrogate of DO2. This could not be completely avoided in the present study; the superior vena caval blood gas was also used as an estimate of the mixed venous oxygen content to calculate SVR and Qs. The derived SVR, Qs, and DO2 in the present study primarily reflect the cerebral vascular bed and may be different from the lower body.23
This difference is most likely to be greater in the induced increases in PaCO
2, because CO2 is a potent cerebral vasodilator in normal subjects,8
as well as in patients after CPB.9,24
As a result, the present data, as those in previous clinical studies, may have overestimated the overall changes in SVR, Qs, and DO2 in response to CO2. In animal studies, this limitation was overcome with direct measurement of aortic flow (Qs) using an ultrasonic flow probe placed at the ascending aorta.2-4
The percentage of increase in Qs was considerably less when compared with that in our patients (15% vs 57%) for the similar range of PaCO
2 changes.2
Therefore, caution is needed when interpreting the increase in Qs and DO2 by CO2 in clinical practice as the overall DO2 to the whole body. As further shown in the present data, the increase in Qs at PaCO
2 from 40 to 60 mm Hg was associated with an increase in ScO2 and a decrease in SsO2, although to a lesser degree (12% ± 4% vs –8% ± 7%). It seems that the increase in Qs is primarily the consequence of a significant increase in cerebral blood flow at a certain cost of splanchnic perfusion. This is not entirely surprising, considering that the systemic vasodilating effect of CO2 occurs predominately in the brain and to some extent in the heart and nonrespiratory skeletal muscles, whereas little occurs in splanchnic organs.25,26
Although ischemic brain injury is a major noncardiac morbidity in patients after the Norwood operation,27,28
the increase in cerebral blood flow may be beneficial for brain function; the tradeoff of flow distribution with splanchnic perfusion may be undesirable in these patients. It has been shown that splanchnic organs may be at a higher risk of ischemia because of the lower critical oxygen extraction compared with the other organs;29
inadequate splanchnic organ perfusion may be associated with adverse post-CPB outcomes.30
It has been reported that gastrointestinal complications are common and related to mortality in patients after the Norwood procedure.31
Therefore, it may be unwise to concentrate on maximizing DO2, ignoring regional and tissue perfusion. Further studies are warranted with direct measurements of both superior and inferior vena caval oxygen saturations in addition to NIRS monitoring to provide a clearer picture of CO2 effects on systemic and cerebral and splanchnic DO2.
Carbon Dioxide Effects: Decreased Systemic Oxygen Consumption Versus Increased Circulating Catecholamines
A significant decrease in VO2 was observed during hypercapnia in neonates after the Norwood procedure. This was accompanied with a significant decrease in central body temperature. This is the second time that this phenomenon has been observed in an intact organism, including animals and humans. The first report was in infants after bidirectional cavopulmonary anastomosis.14
Hypercapnic acidosis exerts dual and opposite effects on metabolism and cardiovascular function.14
Acidosis (respiratory or metabolic) directly depresses and alkalosis stimulates cellular metabolism in isolated cells and organ.32
In intact organisms, acidosis stimulates a significant release of epinephrine and norepinephrine from sympathetic nerve endings and adrenal glands,33,34
thus indirectly stimulating metabolism and cardiovascular function. The opposing effects may be essential to maintain metabolic and circulatory homeostasis. It has been shown that myocardia,35
cerebral,8
and systemic VO2
36,37
remain unchanged or slightly increased in subjects with normal biventricular circulation. The mechanisms for the unique decrease in VO2 were speculated in our previous report,14
as either reduced metabolic response to or decreased release of catecholamines in the unique circulations. In the present study, plasma epinephrine and norepinephrine were measured. The data showed that the baseline levels of epinephrine and norepinephrine at PaCO
2 of 40 mm Hg were markedly higher in our patients compared with healthy humans33
and infants pre-CPB.38
Although it has been well documented that hypothermic CPB for complete correction of congenital heart defects may induce significant increases in circulating epinephrine and norepinephrine, the levels largely return to preoperative baseline at 24 hours.38
It is likely that the present group of neonates remained hemodynamically and metabolically stressed longer. It is somewhat surprising the altitude of increases in epinephrine and norepinephrine in our patients is comparable to that in healthy persons over the similar range of PaCO
2 increase.33
If the release of catecholamines is not the case, the decreased response might be attributable to the deceased VO2 in our patients during hypercapnic acidosis. CPB may decrease the metabolic response to catecholamines.39
The mechanism for the paradoxic changes in VO2 and circulating catecholamines remains unclear, and the clinical implication of the increased circulating catecholamines on cardiovascular function is uncertain. A small increase in heart rate and systemic arterial blood pressure was observed that is consistent with previous findings.33,36
Any increase in cardiovascular work load might be undesirable in these post-Norwood neonates with marginal reserve of cardiovascular function. In addition,
-adrenergic receptor stimulation in the splanchnic vascular bed by epinephrine and norepinephrine may reduce the regional blood flow.40
This might be partly attributable to the decrease in SsO2.
Study Limitations
The order of exposure to the different CO2 tensions was not randomized. However, it is unlikely that the findings were due merely to the sequence of changes because the final CO2 level of 40 mm Hg demonstrated a reversal of changes noted with each previous sequential increase in CO2 tension.
The changes were monitored for 30 minutes at each level of PaCO 2, and therefore we could not address the effects of prolonged or severe hypercapnia. The use of superior vena caval blood as an estimation of the mixed venous gas for the calculations of SVR, Qs, and DO2 may be a limitation and was discussed above.
NIRS was used to estimate cerebral and splanchnic oxygenation in our study. As mentioned above, NIRS measures oxygen saturation in the mixture of arteries, capillaries, and veins in a small part of underlining tissue and thus may not precisely reflect the overall balance of cerebral or splanchnic oxygen transport or precisely measure the regional blood flow or DO2. Nonetheless, in the patients who were sedated and paralyzed, VO2 was minimized. The change in regional oxygen saturation as measured by NIRS may largely reflect the changes in regional blood flow and DO2 (ie, in the brain and splanchnic organs) in our current study.
| Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Zhang, H. Holtby, S. Cai, O. Al Radi, and J. Li Aortic atresia is associated with an inferior systemic, cerebral, and splanchnic oxygen-transport status in neonates after the Norwood procedure Eur J Cardiothorac Surg, March 1, 2011; 39(3): e13 - e21. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |